Skip to main content

Table 1 Comparison of patients with and patients without adipose tissue invasion (n = 735)

From: Active behavior of triple-negative breast cancer with adipose tissue invasion: a single center and retrospective review

 

ATI-negative

ATI-positive

  

Clinical-pathologic features

(N = 121)a b

(N = 614)a c

P Value

χ2d

age (y)e

58.0 ± 13.8 (26-86)

58.2 ± 13.1 (27-99)

0.872

Body mass index (kg/m2)e

22.8 ± 4.3 (13.6-37.7)

23.4 ± 3.8 (14.2-39.7)

0.105

Tumor size (cm)e

0.9 ± 0.7 (0.04-4.4)

2.1 ± 1.5 (0.1-13)

< 0.001

Lymph node involvement

 Negative

103 (89)

357 (59)

< 0.001

37.0 (1)

 Positive

13 (11)

246 (41)

  

Stage (pathological)

 I

97 (85)

265 (45)

< 0.001

63.6 (2)

 II

14 (12)

220 (37)

  

 III

3 (3)

110 (18)

  

Lymphatic vessel invasion

 Negative

108 (89)

385 (64)

< 0.001

29.3 (1)

 Positive

13 (11)

215 (36)

  

Histologic grade

 I, II (low)

64 (53)

388 (64)

0.019

5.5 (1)

 III (high)

57 (47)

216 (36)

  

Menopausal status

 Premenopausal

38 (32)

196 (33)

0.84

0.04 (1)

 Postmenopausal

82 (68)

405 (67)

  
  1. The t-statistics for age, body mass index, and tumor size, respectively, were as follows; 0.16 (df, 733), 1.62 (df, 709), 8.6 (df, 724)
  2. The 95% confidence intervals for age, body mass index, and tumor size were as follows: −2.37, 2.79; −0.13. 1.4; 0.91, 1.45
  3. ATI adipose tissue invasion
  4. aExcept where indicated, data are number of patients, with percentage in parentheses
  5. bData are missing from five patients for lymph node involvement, seven patients for stage and one patient for menopausal status
  6. cData are missing from 11 patients for lymph node involvement, 19 patients for stage, 14 patients for lymphatic vessel invasion
  7. 10 patients for histologic grade, and 13 patients (including a man) for menopausal status
  8. dNumbers in parentheses are the df
  9. eData are means ± standard deviations, with range in parentheses